DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Biogen Idec (NASDAQ: BIIB)

303.55 4.45 (1.49%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $303.55 1.49%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $305.28
Previous Close $299.10
Daily Range $301.32 - $305.28
52-Week Range $245.31 - $358.89
Market Cap $71.7B
P/E Ratio 28.32
Dividend (Yield) $0.00 (0.0%)
Volume 1,828,008
Average Daily Volume 1,696,110
Current FY EPS $13.42

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

This High-Yield Dividend Stock Screams Danger

This high-yield dividend stock may be paying out north of 7%, but its long-term outlook might have investors wisely running in the opposite direction.

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog

3 Stocks Reiterated As A Buy: MU, NTAP, BIIB

5 Health Care Stocks That Need to Play Serious Catch Up

Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog

Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog

Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog

Regeneron/Bayer's Eylea Gets Japanese Approval for DME - Analyst Blog

Biogen Idec, PML Deaths, And Hemophilia Therapies

3 Stocks Dragging The Drugs Industry Downward

See More BIIB News...

BIIB's Top Competitors

BIIB $303.55 (1.49%)
Current stock: BIIB
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
$0.00 (0.00%)
Current stock: